Celldex Therapeutics (CLDX)
Nasdaq • CLDX • US15117B2025
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 14.3% of free float sold short, 6.4 days to cover, cost to borrow 0.4%. Sign up for live short interest data.
Market Cap
2.35b USD | # 3644 in US
Volume
1.34m shares | 46.85m USD
Shares Outstanding
78.53m
Free Float Shares
92.98% | 73.02m
